1-2 of 2
Marisa Valentinetti, RN
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Relapses of Diffuse Large B Cell Lymphoma in Rituximab Era Are Limited to the First Two Years after Frontline Therapy

Tatyana Feldman, MD, Larysa Gromko, MD, Ewelina A Protomastro, MS, Lina Starovoitova, BS, Anthony R. Mato, MD MSCE, Chad Glisch, Mona Sadekh, MD, Benjamin Schoener, MD, Susan Stives, APN, Marisa Valentinetti, RN, Mary Timberg, APN, Pritish K. Bhattacharyya, MD, Kar Fai Chow, MD, Xiao Yang, MD PhD, Alan P Skarbnik, MD, Andre Goy, MD MS
Journal: Blood
Blood (2014) 124 (21): 1307.
https://doi.org/10.1182/blood.V124.21.1307.1307
Published: 2014
Journal Articles

Ricer (Rituximab, Ifosfamide, Carboplatin, Etoposide, Revlimid) Is Well-Tolerated Salvage Regimen in First Relapse/Primary Refractory DLBCL Allowing Consolidation with Autologous Stem Cell Transplant

Tatyana Feldman, MD, Anthony R Mato, MD, Michele L. Donato, MD, Scott D Rowley, MD, Stuart L. Goldberg, MD, Carolanne Carini, RN, Marisa Valentinetti, RN, Judith Smith, RN, Gabriella Gadaleta, RN, APN-C, Coleen Bejot, MSN, NP-C, Susan Stives, APN, Mary Timberg, RN, MSN, OCN, NP-C, Ewelina A Protomastro, BA, Joshua R. Richter, MD, David H. Vesole, MD, PhD, Andrew L Pecora, MD, David S. Siegel, MD, PhD, Andre Goy, MD
Journal: Blood
Blood (2012) 120 (21): 3710.
https://doi.org/10.1182/blood.V120.21.3710.3710
Published: 2012